CVE-2019-17437

PAN-OS: Custom-role users may escalate privileges

Description

An improper authentication check in Palo Alto Networks PAN-OS may allow an authenticated low privileged non-superuser custom role user to elevate privileges and become superuser. This issue affects PAN-OS 7.1 versions prior to 7.1.25; 8.0 versions prior to 8.0.20; 8.1 versions prior to 8.1.11; 9.0 versions prior to 9.0.5. PAN-OS version 7.0 and prior EOL versions have not been evaluated for this issue.

Remediation

Solution:

  • This issue has been resolved in 7.1.25, 8.0.20, 8.1.11, 9.0.5 and all subsequent versions.

Workaround:

  • Remove any untrusted custom-role users from the device or disable their access until fixes can be applied. Restrict access to the device to only trusted users.

Categories

7.8
CVSS
Severity: High
CVSS 3.1 •
CVSS 2.0 •
EPSS 0.13%
Vendor Advisory paloaltonetworks.com
Affected: Palo Alto Networks PAN-OS
Published at:
Updated at:

References

Frequently Asked Questions

What is the severity of CVE-2019-17437?
CVE-2019-17437 has been scored as a high severity vulnerability.
How to fix CVE-2019-17437?
To fix CVE-2019-17437: This issue has been resolved in 7.1.25, 8.0.20, 8.1.11, 9.0.5 and all subsequent versions.
Is CVE-2019-17437 being actively exploited in the wild?
As for now, there are no information to confirm that CVE-2019-17437 is being actively exploited. According to its EPSS score, there is a ~0% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2019-17437?
CVE-2019-17437 affects Palo Alto Networks PAN-OS.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.